Profit improvements (potential) overshadow sales moderation (guidance)
27/01/21 -"Novartis ended 2020 on a decent note, thanks to a sustained sales recovery momentum and impressive margin progression. While 2021 sales momentum is guided to remain in check, an adequate cushion ..."
Pages
71
Language
English
Published on
27/01/21
You may also be interested by these reports :
23/04/24
The Q1 results came in ahead of the consensus as growth was supported by healthy performances across all the focus areas. Consequently, the ...
17/04/24
Q1 sales exceeded expectations, driven by a strong performance from the Companion Animal segment. The Farm Animal segment was however held back by a ...
16/04/24
Preview: Positive 1Q24 driven by clinical developments of portfolio companies
15/04/24
Investor appetite for Merck KGaA (Add, Germany) shares has been somewhat subdued since we last teased the name (15/03/2021). At that time, the ...